All data are based on the daily closing price as of December 24, 2024
d

Daicel

4202.TSE
8.72 USD
0.01
+0.11%

Overview

Last close
8.72 usd
Market cap
2.35B usd
52 week high
10.43 usd
52 week low
7.56 usd
Target price
11.68 usd

Valuation

P/E
6.4942
Forward P/E
N/A
Price/Sales
0.6364
Price/Book Value
0.9757
Enterprise Value
3.73B usd
EV/Revenue
1.0146
EV/EBITDA
4.9816

Key financials

Revenue TTM
3.67B usd
Gross Profit TTM
882.85M usd
EBITDA TTM
671.93M usd
Earnings per Share
1.34 usd
Dividend
0.35 usd
Total assets
5.41B usd
Net debt
1.41B usd

About

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors. In addition, the company offers automobile airbags inflators comprising gas generation devices; pyro-fuses as safety systems for use in products, such as electric vehicles, renewable energy storage, and transmission systems and robots; and gas generators for seat belt pretensioners, as well as engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films. Further, it reuses water for medical care, drinking water, food, and wastewater fields; and provides chiral columns, chiral reagents, pharma excipients, bellocea S7, flavocell(S-equol), konjac ceramide, polyglycerols, urolithin A, and excipients for food, as well as analytical and separation services. The company's products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.
  • Symbol
    4202.TSE
  • Exchange
    TSE
  • Isin
    JP3485800001
  • Country
    Japan
  • Sector
    Basic Materials
  • Industry
    Specialty Chemicals
  • CEO
    Mr. Yoshimi Ogawa
  • Headquarter
    Osaka
  • Web site
    https://www.daicel.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top